LGG
LLY icon

Luts & Greenleigh Group’s Eli Lilly LLY Stock Holding History

Luts & Greenleigh Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
1,033
+25
+2% +$25.5K 0.94% 24
2026
Q1 		$927K Sell
1,008
-25
-2% -$25.3K 0.73% 30
2025
Q4 		$1.11M Buy
1,033
+42
+4% +$40.2K 0.94% 28
2025
Q3 		$756K Sell
991
-53
-5% -$39.4K 0.68% 33
2025
Q2 		$814K Sell
1,044
-20
-2% -$15.5K 0.78% 28
2025
Q1 		$879K Buy
1,064
+79
+8% +$65.7K 0.87% 24
2024
Q4 		$760K Buy
985
+52
+6% +$43.1K 0.75% 31
2024
Q3 		$827K Buy
933
+36
+4% +$32.4K 0.79% 27
2024
Q2 		$812K Buy
+897
New +$718K 0.84% 26
2023
Q4 		$329K Buy
565
+65
+13% +$37.9K 0.42% 43
2023
Q3 		$268K Buy
+500
New +$258K 0.33% 46

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Luts & Greenleigh Group's LLY Position: Q2 2026 in Review

Luts & Greenleigh Group increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $25.5K and bringing the position to 1,033 shares worth $1.24M. The position accounts for 0.94% of the portfolio, ranked #24.

Luts & Greenleigh Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Luts & Greenleigh Group held 1,033 shares of Eli Lilly worth $1.24M as of Q2 2026.
  • Luts & Greenleigh Group bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.94% of Luts & Greenleigh Group's portfolio in Q2 2026, its #24 holding.
  • Luts & Greenleigh Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Luts & Greenleigh Group's 13F filing for Q2 2026, filed 7 Aug 2026.